Carisma Therapeutics Inc at Chardan Genetic Medicines Conference Transcript
Pleasure to introduce our next guest, Dr. Steven Kelly, President and CEO of Carisma Therapeutics. The format for this session is a fireside chat. And so thank you for joining us today.
My pleasure.
Questions & Answers
Yeah. So to start with, can you give us a high-level overview of Carisma and walk us through the key catalysts that we should anticipate over the next year? And then we'll talk about the programs in more detail.
Yeah, absolutely. So Carisma is about a seven-year old company, Penn spin out. And the idea behind it is that the macrophage is an incredibly powerful cell. And so we put our efforts into how do we harness that power and drive it to treat patients with devastating disease like cancer, liver fibrosis, et
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
